HIV-1 latency in monocytes/macrophages

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Human immunodeficiency virus type 1 (HIV-1) infects CD4+ T cells and monocyte/macrophage lineage cells.
• HIV pathogenesis involves T cell depletion and the establishment of latent viral reservoirs.
• While highly active antiretroviral therapy (HAART) improves patient outcomes, it cannot eliminate latent HIV-1 reservoirs.

Purpose of the Study:

• To review the current understanding of HIV-1 latency mechanisms within the monocyte/macrophage lineage.
• To explore strategies for the specific elimination of these neglected latent HIV-1 reservoirs.

Main Methods:

• Review of existing scientific literature on HIV-1 latency.
• Analysis of the role of monocyte/macrophage lineage cells in HIV-1 persistence.
• Discussion of potential therapeutic targets for eliminating latent reservoirs.

Main Results:

• HIV-1 establishes latency not only in resting CD4+ T cells but also in monocyte/macrophage lineage cells (monocytes, macrophages, brain resident macrophages).
• These cells are more resistant to HIV-1-induced apoptosis, serving as stable viral reservoirs.
• Current efforts to eradicate HIV-1 have largely overlooked these monocyte/macrophage reservoirs.

Conclusions:

• Eliminating latent HIV-1 reservoirs in the monocyte/macrophage lineage is critical for achieving a functional cure for HIV-1.
• Further research into the mechanisms of latency in these cells and the development of targeted elimination strategies are necessary.